Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Protocol of a Prospective, Multi-Center, Single-Arm Phase 2 Trial

PURPOSE: Concurrent chemoradiotherapy (cCRT) is the mainstay therapy of locally advanced gastric (G) and gastroesophageal junction (GEJ) cancers with a poor prognosis. Programmed cell death receptor-1 (PD-1) inhibitor has been approved and recommended to treat ≥3 line G/GEJ patients. A significant c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jia, Lu, Xiaofeng, Liu, Qin, Fu, Yao, Liu, Song, Li, Lin, Liu, Fangcen, Fan, Xiangshan, Yang, Ju, Yang, Yang, Zhao, Yang, Guan, Wenxian, Liu, Baorui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211075/
https://www.ncbi.nlm.nih.gov/pubmed/35747712
http://dx.doi.org/10.2147/CMAR.S355687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211075/
https://www.ncbi.nlm.nih.gov/pubmed/35747712
http://dx.doi.org/10.2147/CMAR.S355687

Ejemplares similares